| Product Code: ETC5260657 | Publication Date: Nov 2023 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
The Sweden Contraceptive Drugs Market is projected to witness mixed growth rate patterns during 2025 to 2029. Commencing at 0.08% in 2025, growth builds up to 0.15% by 2029.

The Contraceptive Drugs market in Sweden is projected to grow at a stable growth rate of 0.08% by 2027, highlighting the country's increasing focus on advanced technologies within the Europe region, where Germany holds the dominant position, followed closely by United Kingdom, France, Italy and Russia, shaping overall regional demand.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Contraceptive Drugs Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Contraceptive Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Contraceptive Drugs Market - Industry Life Cycle |
3.4 Sweden Contraceptive Drugs Market - Porter's Five Forces |
3.5 Sweden Contraceptive Drugs Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Sweden Contraceptive Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Sweden Contraceptive Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about family planning and contraception methods |
4.2.2 Growing emphasis on sexual health education and access to contraceptives |
4.2.3 Government initiatives promoting the use of contraceptives |
4.3 Market Restraints |
4.3.1 Social stigma and cultural barriers associated with contraceptive use |
4.3.2 Limited availability and access to a variety of contraceptive options |
4.3.3 Potential side effects and health concerns related to contraceptive drugs |
5 Sweden Contraceptive Drugs Market Trends |
6 Sweden Contraceptive Drugs Market Segmentations |
6.1 Sweden Contraceptive Drugs Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Sweden Contraceptive Drugs Market Revenues & Volume, By Oral, 2021-2031F | 6.1.4 Sweden Contraceptive Drugs Market Revenues & Volume, By Injectable, 2021-2031F |
6.1.4 Sweden Contraceptive Drugs Market Revenues & Volume, By Patches, 2021-2031F |
6.2 Sweden Contraceptive Drugs Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Sweden Contraceptive Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021-2031F |
6.2.3 Sweden Contraceptive Drugs Market Revenues & Volume, By Retail Pharmacy, 2021-2031F |
6.2.4 Sweden Contraceptive Drugs Market Revenues & Volume, By Clinics, 2021-2031F |
6.2.5 Sweden Contraceptive Drugs Market Revenues & Volume, By Online Channel, 2021-2031F |
6.2.6 Sweden Contraceptive Drugs Market Revenues & Volume, By Public Channel & NGOs, 2021-2031F |
6.2.7 Sweden Contraceptive Drugs Market Revenues & Volume, By Others, 2021-2031F |
7 Sweden Contraceptive Drugs Market Import-Export Trade Statistics |
7.1 Sweden Contraceptive Drugs Market Export to Major Countries |
7.2 Sweden Contraceptive Drugs Market Imports from Major Countries |
8 Sweden Contraceptive Drugs Market Key Performance Indicators |
8.1 Number of educational campaigns or initiatives promoting contraceptive use |
8.2 Percentage of the population with access to affordable contraceptives |
8.3 Rate of adoption of long-acting reversible contraceptives (LARCs) among women in Sweden |
9 Sweden Contraceptive Drugs Market - Opportunity Assessment |
9.1 Sweden Contraceptive Drugs Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Sweden Contraceptive Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Sweden Contraceptive Drugs Market - Competitive Landscape |
10.1 Sweden Contraceptive Drugs Market Revenue Share, By Companies, 2024 |
10.2 Sweden Contraceptive Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |